Unruptured Intracranial Aneurysm Clinical Trial
Official title:
Enhanced Versus Standard Blood Pressure Lowering on Intracranial Aneurysm Rupture or Growth China Antihypertensive Trial for Intracranial Aneurysm (ChATIA-1)
The goal of this randomized controlled trial is to evaluate the benefits and safety of controlled hypotension in Chinese patients with unruptured intracranial aneurysms(UIA). The main questions it aims to answer are: - To provide high-level evidence of the benefits and safety of controlled hypotension in patients with UIA. - To provide evidence-based medical evidence for blood pressure control of patients with UIA in neurosurgery, and promote the progress of accurate individual management of patients. In this study, the main intervention is enhanced blood pressure lowering in patients with UIA. All Patients will be randomly assigned to either the standard blood pressure lowering (SBPL) group or the enhanced blood pressure lowering (EBPL) group.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06238115 -
Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair
|
Phase 2/Phase 3 | |
| Completed |
NCT05355259 -
ACtive Catheterization for EndovaScular TreatmentS
|
N/A | |
| Completed |
NCT03989557 -
Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms
|
Phase 4 | |
| Recruiting |
NCT05844163 -
Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)
|
||
| Recruiting |
NCT05491980 -
Florida Cerebrovascular Disease Biorepository and Genomics Center
|
||
| Recruiting |
NCT04578808 -
Unruptured Cerebral Aneurysm: Prediction of Evolution
|